drugset
drugset / Trial / NCT00203723

Use of Risperidone in ECT for Treatment Resistant Depression

NCT00203723 ↗

Phase 4 Terminated 45 enrolled University of California, Los Angeles Janssen, LP · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if the combination of risperidone and ECT improves a patient's response in depression compared to ECT alone.

Timeline

Start
2005-03
Primary completion
—
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified — —

Indications

major depressive disorder